{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T19:38:09Z","timestamp":1777491489322,"version":"3.51.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/17\/28\/32807"],"award-info":[{"award-number":["FS\/17\/28\/32807"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.yjmcc.2022.10.010","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T21:36:17Z","timestamp":1667511377000},"page":"25-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["An endogenous inhibitor of angiogenesis downregulated by hypoxia in human aortic valve stenosis promotes disease pathogenesis"],"prefix":"10.1016","volume":"174","author":[{"given":"Christopher T.A.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith S.","family":"Mascall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather M.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith M.","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith","family":"Buchan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary R.","family":"Small","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme F.","family":"Nixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2022.10.010_bb0005","first-page":"371","article-title":"Aortic stenosis: diagnosis and treatment","volume":"93","author":"Grimard","year":"2016","journal-title":"Am. Fam. Physician"},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0010","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1056\/NEJMra1313875","article-title":"Aortic-valve stenosis \u2014 from patients at risk to severe valve obstruction","volume":"371","author":"Otto","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0015","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/CIRCULATIONAHA.116.023997","article-title":"Medical treatment of aortic stenosis","volume":"134","author":"Marquis-Gravel","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1152\/physiol.00025.2016","article-title":"Pathophysiology of aortic valve stenosis\u00a0: is it both fibrocalcific and sex clinical and surgical","volume":"32","author":"Sritharen","year":"2019","journal-title":"Physiology"},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0025","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1161\/ATVBAHA.109.198267","article-title":"Vascular endothelial growth factor\u2013secreting mast cells and myofibroblasts","volume":"30","author":"Syv\u00e4ranta","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0030","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nm1476","article-title":"Chondromodulin-I maintains cardiac valvular function by preventing angiogenesis","volume":"12","author":"Yoshioka","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0035","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJM199907153410302","article-title":"Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly","volume":"341","author":"Otto","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0040","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11060-017-2477-x","article-title":"The role of bevacizumab in the treatment of glioblastoma","volume":"133","author":"Diaz","year":"2017","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0045","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0959-8049(00)00159-3","article-title":"Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation","volume":"36","author":"Dachs","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0050","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-\u03b1 to the von hippel-lindau ubiquitylation complex by O2- regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0055","doi-asserted-by":"crossref","first-page":"32253","DOI":"10.1074\/jbc.271.50.32253","article-title":"Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its \u03b1 subunit","volume":"50","author":"Huang","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0060","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/359843a0","article-title":"Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis","volume":"359","author":"Shweiki","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0065","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/(SICI)1096-9896(200003)190:4<430::AID-PATH538>3.0.CO;2-6","article-title":"Macrophage infiltration is associated with VEGF and EGFR expression in breast cancer","volume":"190","author":"Leek","year":"2000","journal-title":"J. Pathol."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0070","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1242\/dev.137919","article-title":"Vegfa signals through ERK to promote angiogenesis, but not artery differentiation","volume":"143","author":"Shin","year":"2016","journal-title":"Development"},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0075","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1093\/emboj\/16.13.3898","article-title":"Proteolytic processing regulates receptor specificity and activity of VEGF-C","volume":"16","author":"Joukov","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0080","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0085","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/nature05249","article-title":"Corneal avascularity is due to soluble VEGF receptor-1","volume":"443","author":"Ambati","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0090","first-page":"1992","article-title":"Soluble Tie2 and Flt1 extracellular domains in serum of patients with renal cancer and response to antiangiogenic therapy","volume":"7","author":"Harris","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0095","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/BA20010043","article-title":"Identification of the ligand-binding domain of human vascular-endothelial-growth-factor receptor Flt-1","volume":"34","author":"Ma","year":"2001","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.14336\/AD.2016.0920","article-title":"The soluble VEGF receptor sFlt-1 contributes to impaired neovascularization in aged mice","volume":"8","author":"Zhao","year":"2017","journal-title":"Aging Dis."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0105","doi-asserted-by":"crossref","first-page":"12436","DOI":"10.3390\/ijms160612436","article-title":"Circulating levels of sFlt1 splice variants as predictive markers for the development of preeclampsia","volume":"16","author":"Souders","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0110","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/nbt.4297","article-title":"RNAi modulation of placental sFLT1 for the treatment of preeclampsia","volume":"36","author":"Turanov","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0115","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/01.RES.0000194324.29363.82","article-title":"Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF","volume":"97","author":"Krysiak","year":"2005","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.14336\/AD.2016.0920","article-title":"The soluble VEGF receptor sFlt-1 contributes to impaired neovascularization in aged mice","volume":"8","author":"Zhao","year":"2017","journal-title":"Aging Dis."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.placenta.2008.10.006","article-title":"Novel soluble Flt-1 isoforms in plasma and cultured placental explants from normotensive pregnant and preeclamptic women","volume":"30","author":"Rajakumar","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0130","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0003-4975(99)00439-7","article-title":"Surgical treatment of the dilated ascending aorta: when and how?","volume":"67","author":"Ergin","year":"1999","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0135","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1186\/1532-429X-10-43","article-title":"Detection and quantification of angiogenesis in experimental valve disease with integrin-targeted nanoparticles and 19-fluorine MRI\/MRS","volume":"10","author":"Waters","year":"2008","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0140","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.12836","article-title":"Sphingosine-1-phosphate receptors and innate immunity","volume":"20","author":"Bryan","year":"2018","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1042\/BST20110602","article-title":"Sphingosine 1-phosphate signalling in cancer","volume":"40","author":"Pyne","year":"2012","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0150","doi-asserted-by":"crossref","first-page":"29367","DOI":"10.1074\/jbc.M403937200","article-title":"The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis","volume":"279","author":"Kono","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0155","doi-asserted-by":"crossref","first-page":"637","DOI":"10.14348\/molcells.2014.0150","article-title":"Regulation of wound healing and fibrosis by hypoxia and hypoxia-inducible factor-1","volume":"37","author":"Ruthenborg","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0160","first-page":"7","article-title":"Dynamics of angiogenesis in ischemic areas of the infarcted heart","author":"Kobayashi","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0165","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2459\/JCM.0b013e32802e6c3d","article-title":"Aortic valve stenosis and coronary artery disease: pathophysiological and clinical links","volume":"8","author":"Mazzone","year":"2007","journal-title":"J. Cardiovasc. Med."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0170","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/01913123.2014.991884","article-title":"HIF-1\u03b1 and VEGF: immunohistochemical profile and possible function in human aortic valve stenosis","volume":"39","author":"Perrotta","year":"2015","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0175","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0301-0082(00)00011-3","article-title":"Mechanisms underlying hypoxia-induced neuronal apoptosis","volume":"62","author":"Banasiak","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0180","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1365-2184.2012.00810.x","article-title":"Hypoxia induces apoptosis and autophagic cell death in human periodontal ligament cells through HIF-1\u03b1 pathway","volume":"45","author":"Song","year":"2012","journal-title":"Cell Prolif."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0185","first-page":"576","article-title":"Role of hypoxia-induced transglutaminase 2 in pulmonary artery smooth muscle cell proliferation","volume":"307","author":"Penumatsa","year":"2014","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0190","doi-asserted-by":"crossref","first-page":"12","DOI":"10.14715\/cmb\/2017.63.7.2","article-title":"Hypoxia stimulates neural stem cell proliferation by increasing HIF-1\u03b1 expression and activating Wnt\/\u03b2-catenin signaling","volume":"63","author":"Qi","year":"2017","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0195","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1183\/09031936.00128706","article-title":"The effects of hypoxia on the cells of the pulmonary vasculature","volume":"30","author":"Pak","year":"2007","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0200","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1038\/onc.2016.411","article-title":"Cancer heterogeneity is not compatible with one unique cancer cell metabolic map","volume":"36","author":"Strickaert","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0205","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.placenta.2008.12.010","article-title":"Novel splice variants of sFlt1 are upregulated in preeclampsia","volume":"30","author":"Heydarian","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0210","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1042\/BJ20101490","article-title":"Hypoxia down-regulates sFlt-1 (sVEGFR-1) expression in human microvascular endothelial cells by a mechanism involving mRNA alternative processing","volume":"436","author":"Ikeda","year":"2011","journal-title":"Biochem. J."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0215","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3892\/ijo.2016.3810","article-title":"The anti-angiogenic role of soluble-form VEGF receptor in malignant gliomas","volume":"50","author":"Takano","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0220","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.preghy.2017.07.138","article-title":"sFlt-1 and soluble endoglin concentrations in serum vs plasma in preterm preeclampsia: are they interchangeable for biomarker studies?","volume":"10","author":"Brownfoot","year":"2017","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0225","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/1471-0528.15042","article-title":"Angiogenic factors: potential to change clinical practice in pre-eclampsia?","volume":"125","author":"Cerdeira","year":"2018","journal-title":"BJOG"},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0230","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0235","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(00)03577-7","article-title":"Pathogenesis and genetics of pre-eclampsia","volume":"357","author":"Roberts","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0240","first-page":"1193","article-title":"Expression and localization of angiogenic inhibitory factor, chondromodulin-I, in adult rat eye","volume":"42","author":"Funaki","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0245","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1172\/JCI40973","article-title":"Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents","volume":"120","author":"Hakuno","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0250","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1476-5381.2009.00451.x","article-title":"FTY720 (fingolimod) in multiple sclerosis: therapeutic effects in the immune and the central nervous system","volume":"158","author":"Brinkmann","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0109081","article-title":"Synergy between sphingosine 1-phosphate and lipopolysaccharide signaling promotes an inflammatory, angiogenic and osteogenic response in human aortic valve interstitial cells","volume":"9","author":"Fern\u00e1ndez-Pisonero","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.yjmcc.2022.10.010_bb0260","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/cvr\/cvp312","article-title":"S1P3-mediated cardiac fibrosis in sphingosine kinase 1 transgenic mice involves reactive oxygen species","volume":"85","author":"Takuwa","year":"2010","journal-title":"Cardiovasc. Res."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228282200551X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002228282200551X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:49:35Z","timestamp":1777387775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002228282200551X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":52,"alternative-id":["S002228282200551X"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2022.10.010","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An endogenous inhibitor of angiogenesis downregulated by hypoxia in human aortic valve stenosis promotes disease pathogenesis","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2022.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}